Star Combo Pharma Ltd. (AU:S66)
ASX:S66
Total Valuation
Star Combo Pharma Ltd. has a market cap or net worth of AU$27.00M. The enterprise value is AU$31.21M.
Market CapAU$27.00M
Enterprise ValueAU$31.21M
Share Statistics
Star Combo Pharma Ltd. has 135,002,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding135,002,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Star Combo Pharma Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is -0.55%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)-0.55%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee927.05K
Profits Per Employee174.96K
Employee Count30
Asset Turnover0.57
Inventory Turnover4.33
Valuation Ratios
The current PE Ratio of Star Combo Pharma Ltd. is 21.2. Star Combo Pharma Ltd.’s PEG ratio is 0.01.
PE Ratio21.2
PS Ratio0.86
PB Ratio0.63
Price to Fair Value0.63
Price to FCF2.08
Price to Operating Cash Flow44.81
PEG Ratio0.01
Income Statement
In the last 12 months, Star Combo Pharma Ltd. had revenue of 27.81M and earned 5.25M in profits. Earnings per share was 0.03.
Revenue27.81M
Gross Profit6.27M
Operating Income-237.98K
Pretax Income5.31M
Net Income5.25M
EBITDA6.64M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 602.90K and capital expenditures -348.85K, giving a free cash flow of 254.05K billion.
Operating Cash Flow602.90K
Free Cash Flow254.05K
Free Cash Flow per Share<0.01
Dividends & Yields
Star Combo Pharma Ltd. pays an annual dividend of AU$0.004, resulting in a dividend yield of 1.54%
Dividend Per ShareAU$0.004
Dividend Yield1.54%
Payout Ratio9.49%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.38
52-Week Price Change81.82%
50-Day Moving Average0.21
200-Day Moving Average0.20
Relative Strength Index (RSI)48.58
Average Volume (3m)6.77K
Important Dates
Star Combo Pharma Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Star Combo Pharma Ltd. as a current ratio of 4.40, with Debt / Equity ratio of 21.50%
Current Ratio4.40
Quick Ratio3.55
Debt to Market Cap<0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.24
Taxes
In the past 12 months, Star Combo Pharma Ltd. has paid 63.93K in taxes.
Income Tax63.93K
Effective Tax Rate0.01
Enterprise Valuation
Star Combo Pharma Ltd. EV to EBITDA ratio is 3.67, with an EV/FCF ratio of 2.11.
EV to Sales0.88
EV to EBITDA3.67
EV to Free Cash Flow2.11
EV to Operating Cash Flow2.04
Balance Sheet
Star Combo Pharma Ltd. has AU$18.18M in cash and marketable securities with AU$8.29M in debt, giving a net cash position of AU$9.89M billion.
Cash & Marketable SecuritiesAU$18.18M
Total DebtAU$8.29M
Net CashAU$9.89M
Net Cash Per ShareAU$0.07
Tangible Book Value Per ShareAU$0.21
Margins
Gross margin is 22.73%, with operating margin of -0.86%, and net profit margin of 18.87%.
Gross Margin22.73%
Operating Margin-0.86%
Pretax Margin19.10%
Net Profit Margin18.87%
EBITDA Margin23.86%
EBIT Margin17.98%
Analyst Forecast
The average price target for Star Combo Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.89%
EPS Growth Forecast607.27%